SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001529930-11-000003
Filing Date
2011-12-06
Accepted
2011-12-06 14:53:27
Documents
1
Period of Report
2011-12-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6220
  Complete submission text file 0001529930-11-000003.txt   7629
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Industrial Applications and Services

Mailing Address C/O PHARMACEUTICAL PRODUCT DEVELOPMENT 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
Hill Raymond H (Reporting) CIK: 0001529930 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 111245616